PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine

NCT01441765 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Renal Cell Carcinoma

Interventions

DRUG: CT-011
BIOLOGICAL: DC/RCC fusion vaccine

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]